Skip to content

small surgery in glaucoma patients

Outcomes of bent ab-interno needle Goniectomy(BANG) in primary open angle glaucoma - BANG

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046899
Enrollment
100
Registered
2022-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma Health Condition 2: H401- Open-angle glaucoma

Interventions

Intervention1: Bent ab-interno needle goniectomy(BANG): patients of open angle glaucoma with age related senile cataract, who is already on multiple(4-5) antiglaucoma medications will undergo bent ab-

Sponsors

DR R.P CENTRE FOR OPHTHALMIC SCIENCES, AIIMS NEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with primary open angle or closed angle glaucoma with visually significant senile cataract 2) Target IOP not achieved with maximum of 3 antiglaucoma medications.

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in the study 2. Secondary open angle glaucoma 3. Patient on anti-platelet medications 4. Patient with any bleeding diathesis

Design outcomes

Primary

MeasureTime frame
TO evaluate the intraocular pressure lowering efficacy of bent ab-interno needle Goniectomy(BANG) in patients of primary open angle glaucoma undergoing age related senile catarct surgeryTimepoint: 18 months

Secondary

MeasureTime frame
To lower the number of anti-glaucoma medications used by glaucoma patients thus decreasing the cost and improving the lifestyle and preserving the conjunctiva for future filtration surgeryTimepoint: 18 months

Countries

India

Contacts

Public ContactProfessor Tanuj Dada

Dr R.P Centre for Ophthalmic Sciences, AIIMS, New Delhi

tanujdada@gmail.com9873336315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026